CF PharmTech, Inc. (02652) disclosed that on 27 February 2026, the company repurchased 30,500 of its H shares at a volume-weighted average price of HKD 38.69 per share. This transaction involved a total spending of HKD 1.18 million and represented 0.0101% of the company’s previously issued ordinary shares.

Following the repurchase, the number of issued shares excluding treasury shares stands at 301,727,086, while treasury shares amount to 496,500. The total number of shares of CF PharmTech remains 302,223,586. The mandate to conduct such repurchases was granted on 16 December 2025, with total authorized repurchases of up to 30,222,358 shares.